Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study
暂无分享,去创建一个
E. Rutgers | P. Westenend | S. Linn | T. van Dalen | S. Elias | M. van der Heiden-van der Loo | T. Dalen | C. Smorenburg | A. Kuijer | A. van Bommel | E. Rutgers | M. Loo | A. V. Bommel | P. Westenend | C. Drukker | A. V. van Bommel